Repligen - 48 Year Dividend History | RGEN

Historical dividend payout and yield for Repligen (RGEN) since 1971. The current TTM dividend payout for Repligen (RGEN) as of July 16, 2019 is $0.00. The current dividend yield for Repligen as of July 16, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.059B $0.194B
Repligen Corporation is a life sciences company focused on the development, production and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Their bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. They are a leading manufacturer of Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. They also supply several growth factor products used to increase cell culture productivity during the fermentation stage of drug manufacturing. In addition, they have developed and marketed their OPUS? series of pre-packed `plug-and-play` chromatography columns, and they provide test kits to ensure final product quality. Aside from their core bioprocessing business, they have a portfolio of clinical-stage partnering assets, including a pancreatic imaging agent in Phase 3 development and an orphan drug candidate in Phase 1 development.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.422B 12.15
Gilead Sciences (GILD) United States $86.782B 10.54
CSL (CSLLY) Australia $35.310B 0.00
Bio-Techne Corp (TECH) United States $7.974B 54.41